| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00054725-200411000-00016 |
| P698 | PubMed publication ID | 15626900 |
| P2093 | author name string | R Balfour Sartor | |
| Hans A Büller | |||
| Jan Dekker | |||
| Maria van der Sluis | |||
| Alexandra W C Einerhand | |||
| Mireille K Makkink | |||
| Nicole M J Schwerbrock | |||
| P433 | issue | 6 | |
| P921 | main subject | colitis | Q2453464 |
| P304 | page(s) | 811-823 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Interleukin 10-deficient mice exhibit defective colonic Muc2 synthesis before and after induction of colitis by commensal bacteria | |
| P478 | volume | 10 |
| Q64969898 | Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways. |
| Q38973304 | Clonal evolution of colorectal cancer in IBD. |
| Q44447029 | Ectopic expression of blood type antigens in inflamed mucosa with higher incidence of FUT2 secretor status in colonic Crohn's disease |
| Q35749993 | Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer. |
| Q40002459 | From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD. |
| Q35904634 | Genetically engineered mucin mouse models for inflammation and cancer. |
| Q34518652 | Glutamine Improves Innate Immunity and Prevents Bacterial Enteroinvasion During Parenteral Nutrition. |
| Q82268841 | Host immune response to antibiotic perturbation of the microbiota |
| Q26744656 | Immune Response of Amebiasis and Immune Evasion by Entamoeba histolytica |
| Q93197138 | Intestinal epithelial barrier and neuromuscular compartment in health and disease |
| Q36819342 | Intestinal inflammation targets cancer-inducing activity of the microbiota. |
| Q34137586 | Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer |
| Q38705020 | Mucin-Microbiota Interaction During Postnatal Maturation of the Intestinal Ecosystem: Clinical Implications |
| Q34503629 | Mucin-bacterial interactions in the human oral cavity and digestive tract |
| Q37380400 | Mucin-type O-glycans and their roles in intestinal homeostasis |
| Q24633765 | Mucins in cancer: function, prognosis and therapy |
| Q90571007 | Mucoadhesive role of tamarind xyloglucan on inflammation attenuates ulcerative colitis |
| Q90103700 | PROBIOTICS - A PROBABLE THERAPEUTIC AGENT FOR SPONDYLOARTHROPATHY |
| Q64963829 | Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression. |
| Q36732698 | T-cell activation in the intestinal mucosa |
| Q44698940 | The goblet cell-derived mediator RELM-β drives spontaneous colitis in Muc2-deficient mice by promoting commensal microbial dysbiosis |
| Q34437334 | The gut microbiota, bacterial metabolites and colorectal cancer |
| Q41678805 | The interaction of large bowel microflora with the colonic mucus barrier |
| Q26771122 | Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease |
| Q35478520 | Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome |
Search more.